ResearchInvestment · $97 million
Beacon Biosignals maps brain activity during sleep
MIT News AIhigh confidence
Why it matters
- →The technology allows for non-invasive, at-home monitoring of brain activity, which could lead to earlier detection of neurological disorders. • The integration of machine learning with EEG data may provide insights that traditional methods cannot capture. • The recent funding will accelerate the development of new diagnostic tools and treatments for brain health.
Beacon Biosignals, co-founded by Jake Donoghue and Jarrett Revels, is innovating brain health monitoring with a lightweight headband that uses EEG technology to track brain activity during sleep. This device, which has received FDA clearance, is already being utilized in over 40 clinical trials for various neurological conditions. Recently, the company raised $97 million to enhance its capabilities and expand its reach, aiming to create a comprehensive dataset that could transform the understanding and treatment of brain diseases. By linking sleep data to neurological outcomes, Beacon hopes to enable earlier detection and intervention for conditions like Alzheimer's and Parkinson's disease.
Read originalThe story around this
Earlier coverage that leads up to this article, and what followed. Lines connect each piece to the closest one after it, converging here.
What happened next
- 1Hemispheric Raises $52M to Decode Brain Health with AI
WIRED AI · July 15, 2026 · Background
- 2Samsung unveils AI models for wearable health data
AI News · August 14, 2026 · Background
